Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manhattan Associates Inc (MANH) vs Mesoblast Limited (MESO) Price & Performance

Manhattan Associates IncTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Manhattan Associates Inc vs Mesoblast Limited — how do they compare? Manhattan Associates Inc trades at $189.84 (market cap $11.38B), while Mesoblast Limited trades at $17.03 (market cap $2.21B). The key difference: Manhattan Associates Inc is far larger — about 5.1× Mesoblast Limited's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.

MANHMESO
Market Cap
$11.38B$2.21B
Sector
TechnologyTechnology
52-Week High
$220.19$20.96
52-Week Low
$120.88$12.88
Enterprise Value
$11.25B$2.21B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Manhattan Associates Inc

Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.

Read more on MANH

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO